Shanghai - NAF Pharma Logistics Limited (Shanghai)

NAF Pharma Logistics Limited (Shanghai) stands as a specialized, GDP-certified pharmaceutical cold chain logistics provider created to safeguard the integrity of sensitive medicines and biologicals across Asia. With a focus on reliability, regulatory compliance, and end-to-end supply chain visibility, NAF Pharma combines deep therapeutic logistics expertise with a robust temperature-controlled framework to support pharmaceutical manufacturers, biopharma firms, biotechnology companies, and health science organizations throughout Asia. The company’s footprint extends beyond a single location to enable regional coverage and cross-border capabilities, ensuring that patients receive timely, compliant, and high-quality pharmaceutical products when and where they are needed.

From primary storage to final delivery, NAF Pharma delivers a comprehensive suite of cold chain services designed to protect product quality at every stage of the journey. The organization operates a GDP-certified warehouse near a major aviation and logistics hub in Shanghai, offering a spectrum of temperature control options. These include controlled environments at +2°C to +8°C, +15°C to +25°C, and -25°C to -15°C, complemented by specialized shippers using dry ice and liquid nitrogen, as well as walk-in cool rooms. This multi-range capability is tailored to accommodate a broad array of products, such as biologics, vaccines, vaccines-adjacent therapeutics, clinical trial materials, cell and gene therapies, and other temperature-sensitive shipments. The facility’s positioning near PVG terminal aligns with swift shipments, reduced transit times, and improved coordination with air and sea freight networks, enabling reliable delivery windows for time-critical health products.

Beyond temperature storage, NAF Pharma emphasizes end-to-end logistics that extend from regulatory readiness to post-delivery traceability. The company provides customs documentation advice and export readiness support for clinical trial projects, recognizing that efficient regulatory handling reduces delays and ensures compliance with evolving global and regional requirements. This emphasis on regulatory lifecycle management helps clients maintain trial timelines, meet import-export obligations, and safeguard data integrity across borders. The service portfolio is designed to support complex supply chains, where small-volume, high-value shipments require validated handling, airtight chain-of-custody controls, and frequent temperature monitoring throughout the transport chain.

NAF Pharma’s service philosophy is anchored in a rigorous quality and compliance mindset. The organization states compliance with GDP standards and maintains ISO-certified processes across essential domains, including quality management, environmental stewardship, occupational safety, and medical device quality management, reflecting a holistic, risk-based approach to pharmaceutical logistics. This commitment to regulatory alignment is matched by a disciplined quality culture that emphasizes procedures, validation, and continuous improvement to minimize risk and maximize patient safety. Clients can expect validated packaging solutions, controlled storage, and validated transport routes that adhere to internationally recognized guidelines and local regulatory requirements, ensuring that products reach patients in optimal condition.

The company’s capabilities extend into specialized temperature-sensitive segments that demand more than basic storage. Its temperature-control solutions are designed to support the distribution of biologics and high-value therapeutics that require careful environment management. In addition to general cold chain storage, NAF Pharma offers specialized packaging, validation studies, and monitoring technologies to maintain product integrity during transit. For shipments that require enhanced protection, the availability of dry ice and liquid nitrogen shippers enables validated, cryogenic-grade handling that preserves critical molecular integrity for delicate biologics and cell-based therapies.

NAF Pharma’s end-to-end service model reflects a robust balance between regional scale and localized expertise. The organization highlights a global network of capabilities that facilitate seamless cross-border operations, enabling customers to move shipments across Asia with consistent standards, real-time visibility, and reliable performance. The company fosters a culture of reliability, leveraging a medical courier network, specialized packaging, and validated processes to ensure that shipments arrive at their destinations on time and in the intended condition. This approach is particularly valuable for time-sensitive products, clinical trial samples, patient-specific therapies, and other mission-critical items where delay is not an option.

A core differentiator of NAF Pharma is its breadth of service offerings across the life sciences logistics spectrum. The company emphasizes four marquee pillars: Pharmaceutical Quality Management, Temperature Control Solutions, Our Global Network, and Regular Compliance. Pharmaceutical Quality Management focuses on regulatory compliance, risk mitigation, and the flawless execution of procedures from product development through final patient delivery. Temperature Control Solutions highlight the capability to transport and store temperature-sensitive products with precision, supported by validated packaging and continuous monitoring. The Global Network underscores the ability to deliver seamless logistics and supply chain solutions across cities and continents, leveraging regional expertise to sustain uninterrupted operations. Regular Compliance reflects a robust framework that aligns with GDP, ISO 9001, 14001, 45001, and 13485 standards, enabling risk-free operations and high levels of process reliability.

NAF Pharma has a history rooted in a patient-centered mission. Founded in 2007 in Hong Kong, the company has grown into a trusted partner for the regional life sciences community, underpinned by decades of experience, a broad medical courier network, and rigorous adherence to global quality standards. This founding story underscores a long-standing commitment to delivering dependable, validated logistics for life-saving healthcare solutions. The company’s longevity is complemented by a proven track record of serving global partners with high-value, time-sensitive shipments across Asia, reinforcing its credibility as a reliable partner in pharmaceutical logistics.

In terms of scale and capability, NAF Pharma highlights strong quantitative indicators that illustrate its capacity to support a diverse client base. The company notes more than 17 years of dedicated experience in pharma and cold chain logistics, over 1,000 clients entrusted with sensitive pharmaceuticals, and a distributed network of more than 160 local distributors that enhance its ability to deliver anywhere, anytime. With four regional headquarters strategically placed across Asia, the organization has positioned itself to supervise operations with a regional lens while maintaining the flexibility to adapt to local regulatory environments and customer requirements. This combination of experience, reach, and governance provides clients with a stable, scalable platform for ongoing pharma logistics initiatives.

The mission and value proposition of NAF Pharma are anchored in a customer-centric, risk-mitigated approach to pharma logistics. The company emphasizes its dedication to solving the hardest logistics challenges that life science companies face, from the most time-sensitive clinical trial shipments to routine distribution of high-value products. The emphasis on reliability, precision, and regulatory alignment resonates with clients seeking to minimize risk while maximizing operational efficiency. For partners handling cell and gene therapies and other advanced modalities, NAF Pharma’s dedicated solutions—such as the Cell and Gene Supply Chain and Clinical Trial Logistics—provide specialized capabilities designed to protect product integrity and maintain strict chain-of-custody controls.

NAF Pharma’s thought leadership and capability development are evident in its content and offerings. The company highlights a suite of services that align with modern pharma logistics expectations: end-to-end 3PL with warehousing and distribution in Hong Kong and across Asia, real-time supply chain transparency through digital platforms, and compliance-driven operations supported by a framework of recognized standards. The company’s educational and insight-driven initiatives—evidenced by blog posts and platform updates—signal a commitment to continuous improvement, sharing knowledge with customers and partners to help them navigate the complexities of global pharma logistics.

From a Freightcue platform perspective, NAF Pharma presents a compelling profile for inclusion in a global directory focused on pharma logistics. The company’s demonstrated focus on GDP-certified, temperature-controlled storage and end-to-end regulatory support makes it a strong fit for shippers seeking reliable, compliant partners through Freightcue. Its multi-range temperature capabilities, cryogenic packaging options, and extensive regional reach across Asia align with Freightcue’s mission to connect freight forwarders, logistics providers, and life sciences companies in a transparent, collab-orative marketplace. The combination of strong quality management, regulatory compliance, and a proven track record with more than a thousand client engagements positions NAF Pharma as a potential cornerstone partner for companies seeking dependable cold chain solutions on a regional and cross-border basis. In short, for life sciences shippers and logistics buyers operating on Freightcue, NAF Pharma represents a credible, scalable, and safety-focused option that can enhance supply chain resilience, reduce risk, and support compliant performance across a demanding cold chain ecosystem.